Related Experiment Videos
Summary
Tobacco use is a significant risk factor for ureteral carcinoma. Early diagnosis and prompt treatment are crucial for improving patient prognosis in cases of ureteral cancer.
Area of Science:
- Urology
- Oncology
- Carcinogenesis
Background:
- Tobacco smoking is a known carcinogenic agent implicated in various cancers.
- Ureteral carcinoma, a rare malignancy, requires a high index of suspicion for timely diagnosis.
- Patient history of smoking is a critical factor to consider in ureteral cancer evaluation.
Purpose of the Study:
- To highlight the association between tobacco use and ureteral carcinoma.
- To emphasize the importance of early detection and diagnostic methods for ureteral tumors.
- To present a case of successful treatment for primary ureteral leiomyosarcoma with metastases.
Main Methods:
- Retrospective analysis of patients with ureteral carcinoma.
- Review of diagnostic procedures including endoscopic follow-up, excretory urography, and retrograde studies.
- Utilizing ureteral brush biopsies and tissue sampling with a Dormia basket for diagnosis.
- Case report on the treatment of primary ureteral leiomyosarcoma.
Main Results:
- 77% of patients with ureteral carcinoma had a history of smoking, averaging 50 pack-years.
- Dormia basket biopsies yielded sufficient diagnostic tissue in 3 cases without complications.
- Complete remission of pulmonary metastases was achieved in a patient with primary ureteral leiomyosarcoma treated with doxorubicin hydrochloride and dimethyl-triazeno imidazole carboxamide.
Conclusions:
- A high index of suspicion for ureteral carcinoma is essential, particularly in smokers and patients with lower tract urothelial tumors.
- Minimally invasive diagnostic techniques like Dormia basket biopsy are effective for ureteral tissue sampling.
- Chemotherapy regimens including doxorubicin hydrochloride and dimethyl-triazeno imidazole carboxamide show promise in managing advanced ureteral leiomyosarcoma.